Hotspur Technologies has received CE mark approval for its IQCath Balloon Dilatation Catheter for use within synthetic dialysis access grafts to remove embolic material and dilate obstructive blockages.
The IQCath catheter utilizes Hotspur’s proprietary VisioValve technology which enables these functions to be performed with a single catheter, allowing a physician to perform balloon angioplasty, fluid injection and thrombectomy while maintaining guidewire position.
Hotspur expects to launch the IQCath catheter in select markets outside of the US in the coming months.
Similar to the IQCath catheter , Hotspur’s GPSCath Balloon Dilatation Catheter and Keeper Embolectomy Catheter also utilize the VisioValve technology to combine multiple functions into a single device.
The GPSCath catheter is a specialty two-in-one device that is intended for both dialysis access and peripheral vascular interventions and allows the physician to conduct angioplasty and to inject fluid while maintaining guidewire position.
The Keeper catheter is intended for use within vessels in the arterial system and is another two-in-one device, which integrates an embolectomy balloon with the ability to inject physician-specified fluids while maintaining guidewire position.